Home›Search›Immunotherapy

Immunotherapy

Taylor and Francis Ltd. · United Kingdom · Est. 1922

ISSN1750-7448

SJR Q3✓ WOS SCIE✓ Scopus / SJR

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Top 75% in field

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.666

H-Indexi

SNIPi

0.555

Total Worksi

2,393

Total Citationsi

40,468

2yr Mean Citednessi

1.91

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Immunotherapy publishes research on cancer immunotherapy, including checkpoint blockade, cancer vaccines, adoptive T cell therapy, monoclonal antibodies, and cytokines. It also covers allergen immunotherapy, restorative immunotherapy for HIV and immunocompromised patients, and suppressive immunotherapy for autoimmunity diseases and transplantation. The journal includes basic science of immunotherapeutic approaches and drug-immune system interactions.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1922

FrequencyTwenty-Two Issues A Year, 2024-

StatusActive (last: 2026)

Total Publications2,393

Publisher OrgFuture Medicine

Visit Journal Website

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/11 · 55%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1750-7448

✅

Indexed in a trusted database?

WoS, Scopus, PubMed

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

138

3.3k

2019

162

2.9k

2020

147

1.7k

2021

117

1.3k

2022

159

2023

106

423

2024

135

302

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

ImmunologyQ3

Immunology and AllergyQ3

OncologyQ3

Subject Classification

Web of Science Categories

Immunology

Scopus Categories

ImmunologyImmunology and AllergyOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchImmune Cell Function and InteractionT-cell and B-cell ImmunologyAllergic Rhinitis and SensitizationMonoclonal and Polyclonal Antibodies ResearchAsthma and respiratory diseasesLung Cancer Treatments and MutationsDermatology and Skin Diseases

Frequently asked questions about Immunotherapy

Is Immunotherapy a predatory journal?

PubScope has no integrity flags on record for Immunotherapy: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Immunotherapy?

Immunotherapy is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 1.91.

Is Immunotherapy indexed in Scopus and Web of Science?

Immunotherapy is indexed in Web of Science, Scopus.